首页> Digestive diseases and sciences> Rifaximin Improves Frailty in Patients with Decompensated Cirrhosis: A Randomized Trial.

Rifaximin Improves Frailty in Patients with Decompensated Cirrhosis: A Randomized Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sweta,Rose

第一单位： Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

作者： Sweta,Rose ^[1] ; Muhammad Uwais,Ashraf ^[1] ; Arpit,Shastri ^[1] ; Kannu,Priya ^[1] ; Maryada,Sharma ^[2] ; Harish,Bhujade ^[3] ; Yashwant,Kumar ^[4] ; Sant,Ram ^[5] ; Sahaj,Rathi ^[1] ; Arka,De ^[1] ; Nipun,Verma ^[1] ; Madhumita,Premkumar ^[1] ; Sunil,Taneja ^[6] ; Ajay,Duseja ^[1]

作者单位： Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. ^[1] Department of Otorhinolaryngology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. ^[2] Department of Radiodiagnosis, Postgraduate Institute of Medical Education & Research, Chandigarh, India. ^[3] Department of Immunopathology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. ^[4] Department of Biochemistry, Postgraduate Institute of Medical Education & Research, Chandigarh, India. ^[5] Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. drsuniltaneja20@gmail.com. ^[6]

关键词 Alcohol cirrhosis CTP score Cirrhosis Frailty Hospitalization Liver frailty index MASLD MELD Score Portal hypertension Rifaximin

DOI 10.1007/s10620-025-09660-1

PMID 41579272

发布时间 2026-01-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交